Amlodipine recall 2019

    • [PDF File]Nitrosodiethylamine) Impurity. FOR IMMEDIATE RELEASE: …

      https://info.5y1.org/amlodipine-recall-2019_1_6a1a44.html

      03/04/2019 AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 39 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity. AurobindoPharma USA, Inc. contact 1-866-850-2876 Option 2 Recall being handled by:

      fda recall amlodipine


    • [PDF File]Urgent: Drug Recall

      https://info.5y1.org/amlodipine-recall-2019_1_36eeaa.html

      Urgent: Drug Recall Amlodipine Besylate Tablets, USP 2.5mg, 5mg, 10mg Recall initiated by the Manufacturer: Mylan Pharmaceuticals Inc. Product Distributed by: Mylan Institutional Inc. PRODUCT NDC Name and Strength Size 51079-450-20 Amlodipine Besylate Tablets, USP 2.5 mg UD100

      amlodipine besylate recall 2019


    • [PDF File]USA Recall of All Amlodipine/Valsartan Combination Tablets ...

      https://info.5y1.org/amlodipine-recall-2019_1_e4100a.html

      26X050 4/2019 Amlodipine and Valsartan Tablets 10 mg/320 mg 30 Count 0093-7693-56 5 – Teva Valsartan Combination Class 2 Recall Lot # Exp. Date Product Description / Strength Bottle Size NDC

      2019 recall lupin pharmaceuticals amlodipine


    • [PDF File]Drug Recall List - Blue Cross Blue Shield of Michigan

      https://info.5y1.org/amlodipine-recall-2019_1_f0a853.html

      * Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

      dangers of amlodipine besylate


    • [PDF File]Valsartan and Amlodipine and Valsartan tablets

      https://info.5y1.org/amlodipine-recall-2019_1_84871c.html

      Drug recall notice for Valsartan and Amlodipine and Valsartan tablets AurobindoPharma USA, Inc. is conducting a voluntary recall expansion of 38 lots of Valsartan and Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an unexpected impurity ... 4/3/2019 …

      norvasc recall 2019


    • [PDF File]Irebesartan products under recall

      https://info.5y1.org/amlodipine-recall-2019_1_869585.html

      Irbesartan products under recall - Updated April 15, 2019. Title: Irebesartan products under recall Author: FDA Created Date: 4/16/2019 4:36:45 PM ...

      amlodipine 5 mg blood pressure


    • [PDF File]Valsartan/HCTZ, valsartan/amlodipine and valsartan ...

      https://info.5y1.org/amlodipine-recall-2019_1_2752ae.html

      Updated information about this recall. Your safety, health and well-being are important to us. We want to let you know that n oAugust 24, 2018, the U.S. Food and Drug Administration (FDA) expanded its voluntary, nationwide recall of certain

      list of recalled losartan tablets


    • valsartan products under recall

      Aurobindo Pharma USA, Inc. Amlodipine/Valsartan 5mg/320mg Tablet 65862-738-30 VMSA17017-A 11/2019 Aurobindo Pharma USA, Inc. Amlodipine/Valsartan 10mg/160mg Tablet 65862-739-30 VFSA17008-A 10/2019 ...

      why is amlodipine dangerous


    • [PDF File]Torrent – Recall of Amlodipine/Valsartan/Hydrochlorothiazide

      https://info.5y1.org/amlodipine-recall-2019_1_996778.html

      taking or using the recalled amlodipine/valsartan/HCTZ. • On July 13th, the FDA initiated a series of announcements regarding the recall of certain batches of valsartan and valsartan-HCTZ tablets because of unacceptable levels of NDMA.

      fda recall amlodipine


    • [PDF File]Additional Recalled Lot Number Recall of Valsartan ...

      https://info.5y1.org/amlodipine-recall-2019_1_08bb11.html

      Mar 07, 2019 · Recall of Valsartan-Containing Products by Aurobindo Effective Date: March 6, 2019 On February 25, 2019, Aurobindo announced a voluntary recall of several lots of Valsartan and Amlodipine / Valsartan tablets because of the presence of trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA), found in the finished product.

      amlodipine besylate recall 2019


Nearby & related entries: